INHIBITION OF NNMT, A KIDNEY FAILURE-ASSOCIATED GENE INDENTIFIED BY TRANSCRIPTOMIC ANALYSIS, BLOCKS PROGRESSION OF DKD IN MICE

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
INHIBITION OF NNMT, A KIDNEY FAILURE-ASSOCIATED GENE INDENTIFIED BY TRANSCRIPTOMIC ANALYSIS, BLOCKS PROGRESSION OF DKD IN MICE

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
WenJun
Ju
WenJun Ju wenjunj@med.umich.edu University of Michigan Internal Medicine-Nephrology Ann Arbor United States *
Maria Strömstedt maria.stromstedt@astrazeneca.com Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca BioPharmaceuticals R&D Gothenburg Sweden -
Yufeng Huang yufeng.huang@hsc.utah.edu University of Utah School of Medicine Primary-Internal Medicine Salt Lake City United States -
Anders Johansson Anders.M.Johansson@astrazeneca.com Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca BioPharmaceuticals R&D Gothenburg Sweden -
Lars Löfgren Lars.Lofgren@astrazeneca.com Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca BioPharmaceuticals R&D Gothenburg Sweden -
Birgitta Rosengren Birgitta.Rosengren@astrazeneca.com Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca BioPharmaceuticals R&D Gothenburg Sweden -
Viji Nair vijin@med.umich.edu University of Michigan Internal Medicine-Nephrology Ann Arbor United States -
Sean Eddy seaneddy@med.umich.edu University of Michigan Internal Medicine-Nephrology Ann Arbor United States -
Christopher O'Connor oconnoc@med.umich.edu University of Michigan Internal Medicine-Nephrology Ann Arbor United States -
Sulalita Chaki schaki@med.umich.edu University of Michigan Internal Medicine-Nephrology Ann Arbor United States -
Markus Bitzer markusbi@med.umich.edu University of Michigan Internal Medicine-Nephrology Ann Arbor United States -
Anna Reznichenko Anna.Reznichenko@astrazeneca.com Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca BioPharmaceuticals R&D Gothenburg Sweden -
Pernille BL Hansen pbhansen@health.sdu.dk Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca BioPharmaceuticals R&D Gothenburg Sweden -
Ola Fjellström Ola.Fjellstrom@astrazeneca.com Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca BioPharmaceuticals R&D Gothenburg Sweden -
Matthias Kretzler kretzler@med.umich.edu University of Michigan Internal Medicine-Nephrology Ann Arbor United States -